All lobbying filings

Milne, Wiener & Shofe Global Strategies (FKA M & W Government Affairs, LLC)

Milne, Wiener & Shofe Global Strategies (FKA M & W Government Affairs, LLC) filed a Q1 report for Rafa Laboratories, Ltd. on April 21, 2025, reporting $50,000 in lobbying income.

Lobbying for Rafa Laboratories, Ltd. · Rafa is an Israeli pharmaceutical company in operation for more than 80 years.

As filed: MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC) for RAFA LABORATORIES, LTD.

All filings by Milne, Wiener & Shofe Global Strategies (FKA M & W Government Affairs, LLC) · Everything Rafa Laboratories, Ltd. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$50,000

What the client paid this registrant for the period.

Official filing document

Lobbyists on this filing 3

JEFFREY S WIENER

Previously held: Military Legislative Assistant to Former Senator Mary Landrieu (D-LA)
ALLEN SHOFE

Previously held: Chief of Staff to Former Representative Gil Gutknecht (R-MN)
CRAIG ROBERTS New on this filing

Previously held: Chief of Staff to Former Congressman John Shimkus

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile

Defense

Advocating for the procurement of midazolam autoinjectors and atropine autoinjectors for the Department of Defense

Budget/Appropriations

Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile, as well as for procurement by of the same autoinjectors by the Department of Defense. Advocated for procurement in the FY25 Continuing Resolution and the upcoming FY26 Approprations process.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.